TransDigm Issues Fiscal 2027 Revenue Guidance and Outlines M&A Strategy
During its fourth quarter fiscal 2026 earnings call, TransDigm (TDG) provided a revenue guidance midpoint of $12.05 billion for fiscal 2027, signaling expected double-digit growth in key aerospace markets. The company highlighted its disciplined capital allocation strategy, noting that it repurchased $2.75 billion in stock and deployed $4.4 billion across 16 acquisitions during the 2026 fiscal year. Management emphasized a decentralized acquisition model where 57 operating units identify 'bolt-on' opportunities to mitigate risk. Additionally, leadership expressed confidence in their proprietary intellectual property, which shields the defense business from right-to-repair legislation. With over $10 billion in remaining M&A capacity and a focus on factory automation, TransDigm aims to drive margin expansion despite rising OEM production rates.
Coverage
- Twist Bioscience Exceeds Q4 Earnings and Revenue Estimates, Issues Strong Fiscal 2027 Guidance
- BrightView Holdings Issues Fiscal 2027 Revenue and Free Cash Flow Guidance
- TransDigm Issues Fiscal 2027 Revenue Guidance and Outlines M&A Strategy
- Mesa Laboratories Issues Fiscal 2027 Revenue Guidance and Announces $40 Million Share Buyback
- Orion Energy Raises Fiscal 2027 Revenue Guidance Amid Data Center and Retail Growth